However, there seemed to be no significant alteration of TNF-α (Figure 3I) between the two groups, indicating that endothelial BRG1 deletion could alleviate AAA progression via regulating IL-1β and IL-6 levels. The gene discussed is TNF; the disease is triple-A syndrome.